159 related articles for article (PubMed ID: 38657230)
1. Real-World Registry on the Pharmacotherapy of Multiple Myeloma and Associated Renal and Pulmonary Impairments in the Greater Gulf Region: Protocol for a Retrospective Real-World Data Study.
Nourallah A; Alshehri A; Alhejazi A; Usman B; ElGohary G; Malhan H; Motabi I; Al Farsi K; Alshuaibi M; Siddiqui M; Ghonema R; Taha RY; Abouzeid T; Ahmed W; Diab M; Alhuraiji A; Rabea M; Chouikrat MZ
JMIR Res Protoc; 2024 Apr; 13():e49861. PubMed ID: 38657230
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study.
Cohen YC; Magen H; Lavi N; Gatt ME; Chubar E; Horowitz N; Kreiniz N; Tadmor T; Trestman S; Vitkon R; Rouvio O; Shvetz O; Shaulov A; Ziv-Baran T; Avivi I
Ann Hematol; 2020 Jun; 99(6):1273-1281. PubMed ID: 32193630
[TBL] [Abstract][Full Text] [Related]
4. Systematic thematic review of e-health research in the Gulf Cooperation Council (Arabian Gulf): Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and United Arab Emirates.
Weber AS; Turjoman R; Shaheen Y; Al Sayyed F; Hwang MJ; Malick F
J Telemed Telecare; 2017 May; 23(4):452-459. PubMed ID: 27236702
[TBL] [Abstract][Full Text] [Related]
5. Hemodialysis delivery, dialysis dose achievement, and vascular access types in hemodialysis patients from the Gulf Cooperation Council countries enrolled in the dialysis outcomes and practice patterns study phase 5 (2012-2015).
AlYousef A; AlGhareeb S; Al Wakeel J; Al-Ghamdi SM; Bieber BA; Hassan M; Al Maimani Y; Alkandari N; Ahmed HZ; Fawzy A; Pisoni RL;
Saudi J Kidney Dis Transpl; 2016 Nov; 27(6 Suppl 1):S42-50. PubMed ID: 27991478
[TBL] [Abstract][Full Text] [Related]
6. Randomized Clinical Trial Representativeness and Outcomes in Real-World Patients: Comparison of 6 Hallmark Randomized Clinical Trials of Relapsed/Refractory Multiple Myeloma.
Chari A; Romanus D; Palumbo A; Blazer M; Farrelly E; Raju A; Huang H; Richardson P
Clin Lymphoma Myeloma Leuk; 2020 Jan; 20(1):8-17.e16. PubMed ID: 31722839
[TBL] [Abstract][Full Text] [Related]
7. The impact of age and comorbidities on practice patterns and outcomes in patients with relapsed/refractory multiple myeloma in the era of novel therapies.
Hari P; Romanus D; Luptakova K; Blazer M; Yong C; Raju A; Farrelly E; Labotka R; Morrison VA
J Geriatr Oncol; 2018 Mar; 9(2):138-144. PubMed ID: 29056336
[TBL] [Abstract][Full Text] [Related]
8. Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma.
Bruno AS; Willson JL; Opalinska JM; Nelson JJ; Lunacsek OE; Stafkey-Mailey DR; Willey JP
Expert Rev Hematol; 2020 Sep; 13(9):1017-1025. PubMed ID: 32844683
[TBL] [Abstract][Full Text] [Related]
9. Daratumumab monotherapy for relapsed/refractory multiple myeloma, focussed on clinical trial-unfit patients and subsequent therapy.
Park SS; Min Byun J; Yoon SS; Kim K; Jung SH; Lee JJ; Min CK
Br J Haematol; 2021 Apr; 193(1):101-112. PubMed ID: 33368165
[TBL] [Abstract][Full Text] [Related]
10. Asthma control factors in the Gulf Cooperation Council (GCC) countries and the effectiveness of ICS/LABA fixed dose combinations: a dual rapid literature review.
Noibi S; Mohy A; Gouhar R; Shaker F; Lukic T; Al-Jahdali H
BMC Public Health; 2020 Aug; 20(1):1211. PubMed ID: 32770967
[TBL] [Abstract][Full Text] [Related]
11. Renal impairment and use of nephrotoxic agents in patients with multiple myeloma in the clinical practice setting in the United States.
Qian Y; Bhowmik D; Bond C; Wang S; Colman S; Hernandez RK; Cheng P; Intorcia M
Cancer Med; 2017 Jul; 6(7):1523-1530. PubMed ID: 28612485
[TBL] [Abstract][Full Text] [Related]
12. Effect of temperature and humidity on the dynamics of daily new cases and deaths due to COVID-19 outbreak in Gulf countries in Middle East Region.
Meo SA; Abukhalaf AA; Alomar AA; Alsalame NM; Al-Khlaiwi T; Usmani AM
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7524-7533. PubMed ID: 32706095
[TBL] [Abstract][Full Text] [Related]
13. Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009-2018.
Moradi N; Sharmin S; Malpas C; Ozakbas S; Shaygannejad V; Terzi M; Boz C; Yamout B; Turkoglu R; Karabudak R; Hamdy S; Soysal A; Altıntaş A; Inshasi J; Al-Harbi T; Alroughani R; Kalincik T;
CNS Drugs; 2021 Oct; 35(10):1097-1106. PubMed ID: 34164782
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) across the Gulf Corporation Council countries: Four years update.
Aly M; Elrobh M; Alzayer M; Aljuhani S; Balkhy H
PLoS One; 2017; 12(10):e0183850. PubMed ID: 29028812
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness and safety of lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma in real-world clinical practice: a study of the Korean Multiple Myeloma Working Party (KMMWP-151 study).
Jo JC; Lee HS; Kim K; Lee JJ; Yoon SS; Bang SM; Kim JS; Eom HS; Yoon DH; Lee Y; Shin HJ; Park Y; Lee WS; Do YR; Mun YC; Lee MH; Kim HJ; Kim SH; Kim MK; Lim SN; Cho SH; Park SK; Yi JH; Lee JH; Kim J; Min CK;
Ann Hematol; 2020 Feb; 99(2):309-319. PubMed ID: 31872360
[TBL] [Abstract][Full Text] [Related]
16. From guidelines to real world: results from the National Multiple Myeloma Registry in Uruguay on 222 newly diagnosed multiple myeloma patients from 2012 to 2015.
Riva E; Bove V; Villano F; Mori M; Córdoba C; Noria A; Petruskevicius P; Cardeza A; Díaz L
Curr Med Res Opin; 2019 Jul; 35(7):1197-1203. PubMed ID: 30621522
[No Abstract] [Full Text] [Related]
17. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
18. Real-world treatment patterns and associated progression-free survival in relapsed/refractory multiple myeloma among US community oncology practices.
Jagannath S; Roy A; Kish J; Lunacsek O; Globe D; Eaddy M; Kuriakose ET; Willey J; Butler-Bird S; Siegel D
Expert Rev Hematol; 2016 Jul; 9(7):707-17. PubMed ID: 27291638
[TBL] [Abstract][Full Text] [Related]
19. A Call for More Research from the Arabian Gulf.
AlMarri F; Al Sabah S; Al Haddad E; Vaz JD
Obes Surg; 2017 Aug; 27(8):2034-2043. PubMed ID: 28236255
[TBL] [Abstract][Full Text] [Related]
20. Multiple Myeloma in Hispanics: Incidence, Characteristics, Survival, Results of Discovery, and Validation Using Real-World and Connect MM Registry Data.
Kaur G; Mejia Saldarriaga M; Shah N; Catamero DD; Yue L; Ashai N; Goradia N; Heisler J; Xiao Z; Ghalib N; Aaron T; Cole D; Foreman R; Mantzaris I; Derman O; Bachier L; Sica RA; Kornblum N; Braunschweig I; Shastri A; Goel S; Verma A; Janakiram M
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):e384-e397. PubMed ID: 33339770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
